With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
Tag: Biotech
-
BD and Waters set completion date for $17.5B biosciences and diagnostics merger
With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
-
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).